
Sign up to save your podcasts
Or


The United States stands at a pivotal juncture in eliminating HIV. Despite recent advancements, including the development of an effective new form of pre-exposure prophylaxis (PrEP), an uncertain future marked by cuts to Medicaid and research hurdles threatens to undo the country's progress. In this episode: Jeremiah Johnson, Executive Director of PrEP4All, sheds light on the urgent need for equitable access to PrEP and what's at stake if we fail to scale up initiatives to test, prevent, and treat HIV.
Guest:Jeremiah Johnson is the Executive Director of PrEP4All—an organization that seeks to prevent the spread of HIV by identifying data-driven policy solutions to increase access to PrEP.
Host:Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department.
Show links and related content:Trump's Policies Could Undermine the Fight to End America's HIV Epidemic—Tradeoffs
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option—CNBC
Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic—Journal of Law, Medicine & Ethics
A National PrEP Program to End the Nation's HIV Epidemic—Public Health On Call (April 2022)
Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel.
Contact us:Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.
Follow us:@PublicHealthPod on Bluesky
@JohnsHopkinsSPH on Instagram
@JohnsHopkinsSPH on Facebook
@PublicHealthOnCall on YouTube
Here's our RSS feed
Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.
By The Johns Hopkins Bloomberg School of Public Health4.6
618618 ratings
The United States stands at a pivotal juncture in eliminating HIV. Despite recent advancements, including the development of an effective new form of pre-exposure prophylaxis (PrEP), an uncertain future marked by cuts to Medicaid and research hurdles threatens to undo the country's progress. In this episode: Jeremiah Johnson, Executive Director of PrEP4All, sheds light on the urgent need for equitable access to PrEP and what's at stake if we fail to scale up initiatives to test, prevent, and treat HIV.
Guest:Jeremiah Johnson is the Executive Director of PrEP4All—an organization that seeks to prevent the spread of HIV by identifying data-driven policy solutions to increase access to PrEP.
Host:Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department.
Show links and related content:Trump's Policies Could Undermine the Fight to End America's HIV Epidemic—Tradeoffs
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option—CNBC
Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic—Journal of Law, Medicine & Ethics
A National PrEP Program to End the Nation's HIV Epidemic—Public Health On Call (April 2022)
Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel.
Contact us:Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.
Follow us:@PublicHealthPod on Bluesky
@JohnsHopkinsSPH on Instagram
@JohnsHopkinsSPH on Facebook
@PublicHealthOnCall on YouTube
Here's our RSS feed
Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

43,594 Listeners

40 Listeners

5 Listeners

27 Listeners

4 Listeners

262 Listeners

56,545 Listeners

496 Listeners

9 Listeners

45 Listeners

93 Listeners

16,351 Listeners

16 Listeners

4,762 Listeners

2 Listeners

4,485 Listeners

391 Listeners

6,543 Listeners

25 Listeners

6,394 Listeners

238 Listeners

66 Listeners

163 Listeners

98 Listeners